BY: LEIGH MACMILLAN Combining two targeted cancer therapies may overcome the resistance that some lung tumors develop during treatment, according to a recent report in the Journal of Clinical Investigation. The study, which tested the drug combo in...

BY: PAUL GOVERN Personalized medicine holds increasing promise for improving health care outcomes and preventing adverse drug events, and smack at the forefront of institutions set to usher in this new approach to care is Vanderbilt University Medical...

BY: DAGNY STUART Leora Horn, M.D., has joined Vanderbilt-Ingram Cancer Center as an assistant professor in Hematology/Oncology, specializing in lung cancer. The native of Johannesburg, South Africa, spent 20 years in Canada, where she earned an...

BY: DAGNY STUART Vanderbilt teams participated in several cancer walks this year, setting new records for the amount of money pledged for cancer research. Vanderbilt won the largest health care team award at the Susan G. Komen Race for the Cure for...

BY: DAGNY STUART When Nashville restaurateur Craig Clifft’s daughter, Cattie, was 22 months old, she was diagnosed with acute lymphocytic leukemia (ALL), a type of cancer in which the bone marrow produces too many white blood cells, or lymphocytes,...